Narges Jokar

437 total citations
25 papers, 286 citations indexed

About

Narges Jokar is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Narges Jokar has authored 25 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Narges Jokar's work include Radiopharmaceutical Chemistry and Applications (13 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (4 papers). Narges Jokar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (4 papers). Narges Jokar collaborates with scholars based in Iran, United States and Germany. Narges Jokar's co-authors include Majid Assadi, Hojjat Ahmadzadehfar, Esmail Jafari, Seyed Javad Rekabpour, Iraj Nabipour, Ghasemali Divband, Ali Gholamrezanezhad, Irina Velikyan, Hans‐Jürgen Biersack and Hong Hoi Ting and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Pharmaceutical Design and Frontiers in Oncology.

In The Last Decade

Narges Jokar

21 papers receiving 285 citations

Peers

Narges Jokar
Miriam Sraieb Germany
Fiona E. Scott Australia
Weizhi Xu China
Laura B. Jeffords United States
Riena P. Aliredjo Netherlands
Canan Can Türkiye
Jinming Yu China
Kevin Lee Min Chua Singapore
Weiyan Shi China
Miriam Sraieb Germany
Narges Jokar
Citations per year, relative to Narges Jokar Narges Jokar (= 1×) peers Miriam Sraieb

Countries citing papers authored by Narges Jokar

Since Specialization
Citations

This map shows the geographic impact of Narges Jokar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narges Jokar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narges Jokar more than expected).

Fields of papers citing papers by Narges Jokar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narges Jokar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narges Jokar. The network helps show where Narges Jokar may publish in the future.

Co-authorship network of co-authors of Narges Jokar

This figure shows the co-authorship network connecting the top 25 collaborators of Narges Jokar. A scholar is included among the top collaborators of Narges Jokar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narges Jokar. Narges Jokar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jafari, Esmail, et al.. (2025). Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular Imaging. Academic Radiology. 32(11). 6823–6839. 1 indexed citations
2.
3.
4.
Jokar, Narges, et al.. (2023). Estimating the risk of cancer incidence and radiation-induced cancer death of children patients undergoing digital radiology X-ray examinations. Journal of Radiation Research and Applied Sciences. 16(4). 100733–100733. 1 indexed citations
5.
Jokar, Narges, et al.. (2023). PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach. PubMed. 3. 1103262–1103262. 7 indexed citations
6.
Dadgar, Habibollah, et al.. (2022). Comparison of 18F-NaF Imaging, 99mTc-MDP Scintigraphy, and 18F-FDG for Detecting Bone Metastases. SHILAP Revista de lepidopterología. 21(1). 1–8. 17 indexed citations
7.
Assadi, Majid, Reyhaneh Manafi‐Farid, Esmail Jafari, et al.. (2022). Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA. Frontiers in Oncology. 12. 1066926–1066926. 17 indexed citations
8.
Kalantarhormozi, Mohammadreza, Seyed Javad Rekabpour, Esmail Jafari, et al.. (2022). Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE in Advanced Neuroendocrine Tumors (NETs) in a Limited-Resource Environment. SHILAP Revista de lepidopterología. 21(3). 215–221. 5 indexed citations
9.
Assadi, Majid, et al.. (2021). The online attention to certain nuclear medicine topics: An altmetrics study vs. a citation analysis. 29(2). 65–72.
10.
Jokar, Narges, et al.. (2021). State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach. Nuclear Medicine Review. 24(2). 82–92. 4 indexed citations
11.
Nemati, Reza, Hojjat Ahmadzadehfar, Mariam Aboian, et al.. (2021). Theranostics in Brain Tumors. PET Clinics. 16(3). 397–418. 14 indexed citations
12.
Assadi, Majid, Narges Jokar, Anna Yordanova, et al.. (2021). Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders. PET Clinics. 16(3). 429–440. 1 indexed citations
13.
Gholamrezanezhad, Ali, et al.. (2021). A Path to New Normal of Nuclear Medicine Facilities: Considerations for Reopening.. SHILAP Revista de lepidopterología. 9(1). 80–85. 1 indexed citations
14.
Assadi, Majid, Seyed Javad Rekabpour, Esmail Jafari, et al.. (2021). Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers. Clinical Nuclear Medicine. 46(11). e523–e530. 111 indexed citations
15.
Jokar, Narges, et al.. (2021). Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication. Clinical and Translational Imaging. 9(6). 561–578. 2 indexed citations
16.
Assadi, Majid, et al.. (2020). Precision Medicine Approach in Prostate Cancer. Current Pharmaceutical Design. 26(31). 3783–3798. 10 indexed citations
17.
Hm, Wang, et al.. (2020). Imaging of the muscle and bone from benchtop to bedside.. PubMed. 24(6). 3254–3266. 1 indexed citations
18.
Gholamrezanezhad, Ali, et al.. (2019). Radioimmunotherapy (RIT) in Brain Tumors. Nuclear Medicine and Molecular Imaging. 53(6). 374–381. 10 indexed citations
19.
Jokar, Narges, et al.. (2019). Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies. SHILAP Revista de lepidopterología. 18(4). 345–350. 1 indexed citations
20.
Jokar, Narges, et al.. (2019). Emerging ionizing and non-ionizing radiation treatment for musculoskeletal disorders and malignancies. 2(4). 54–65.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Sraieb Breakdown of academic impact, for papers by Fiona E. Scott Breakdown of academic impact, for papers by Weizhi Xu Breakdown of academic impact, for papers by Laura B. Jeffords Breakdown of academic impact, for papers by Riena P. Aliredjo Breakdown of academic impact, for papers by Canan Can Breakdown of academic impact, for papers by Jinming Yu Breakdown of academic impact, for papers by Kevin Lee Min Chua Breakdown of academic impact, for papers by Weiyan Shi
Rankless by CCL
2026